OTC Healthcare in Australia published by Euromonitor International in May, 2009. This report consists of Tables: 125 and the price starts from US $ 2400.
Abstract
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive
environment
Product coverage
Adult mouth care; Allergy care; Analgesics; Calming and sleeping products;
Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies;
Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated
skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; OTC triptans;
Vitamins and dietary supplements; Wound treatments
Executive summary
OTC healthcare continues to grow steadily
Steady growth was maintained in OTC healthcare over the review period, with
particularly strong performances by NRT smoking cessation aids and emergency
contraception. Growth in NRT smoking cessation aids was driven by the
government' s efforts to increase public awareness of smoking-related health
ailments, as well as the imposition of restrictions on smoking in public.
Meanwhile, emergency contraception was propelled by the positive reception of
a new product riding on the convenience and ease of use factor. With the
rising prevalence of obesity in Australia, there was moderate growth in OTC
obesity and digestive remedies, as consumers embarked on more weight-loss
activities and sought remedies for gastrointestinal complaints, which tend to
be exacerbated by weight issues.
Symbion Health Ltd undergoes multiple acquisitions
Symbion Health Ltd had an eventful 2008, with considerable takeover activity
over the course of the year. Within months of acquiring Symbion in April 2008,
Primary Health Care Ltd announced its intention to sell the company to fund
the debt resulting from the takeover. Significant interest was expressed by
domestic players, such as Sigma Pharmaceuticals Pty Ltd, Australian
Pharmaceutical Industries Ltd and Metcash Trading Ltd. Metcash Trading saw
this as an opportunity to diversify away from the company' s core business of
grocery wholesaling and retailing. However, in August 2008, foreign-based
Sanofi-Aventis eventually secured the consumer division of Symbion Health Ltd.
Symbion Health Ltd retains lead in OTC healthcare
Despite undergoing two rounds of acquisition, Symbion Health Ltd maintained
the lead in OTC healthcare in 2008, due largely to its continuing strong
performance in vitamins and dietary supplements. The company is also present
in analgesics, digestive remedies, medicated skin care and adult mouth care.
Symbion Health was followed by Johnson & Johnson Pacific Pty Ltd, domestic
company Blackmores Ltd and GlaxoSmithKline Australia Pty Ltd. Johnson &
Johnson Pacific Pty Ltd performed well in several OTC healthcare sectors,
including medicated skin care and digestive remedies, while GlaxoSmithKline
continued to feature strongly in analgesics and NRT smoking cessation aids.
Retail pressure heat up as grocery retailers continue to strengthen
Chemists/pharmacies continue to face increasing competition from grocery
retailers, especially major supermarkets such as Woolworths and Coles. To
raise their competitiveness, chemists/pharmacies engaged in price discounting,
but this met with aggressive rivalry from Internet retailers. On the other
hand, direct selling remains a small contributor to OTC healthcare in 2008.
This channel deals mainly in nutritional products and carries a smaller range
of OTC healthcare products as compared to grocery retailers.
Moderate growth expected over forecast period
OTC healthcare is expected to achieve moderate growth over the forecast
period, with continuing strong growth in emergency contraception and NRT
smoking cessation aids. The interest in preventive health measures will also
drive moderate increases in vitamins and dietary supplements. The ageing of
the population is expected to contribute to growth in digestive remedies and
eye care, while rising obesity in Australia will encourage a pick-up in OTC
obesity products.
Table of Contents
- OTC HEALTHCARE IN AUSTRALIA : MARKET INSIGHT
- EXECUTIVE SUMMARY
- OTC healthcare continues to grow steadily
- Symbion Health Ltd undergoes multiple acquisitions
- Symbion Health Ltd retains lead in OTC healthcare
- Retail pressure heat up as grocery retailers continue to strengthen
- Moderate growth expected over forecast period KEY TRENDS AND DEVELOPMENTS
- Convenience featuring highly in both product development and distribution
- Preference for branded products over generics and private label
- Child-specific products experience growth
- Negative publicity associated with side effects of OTC healthcare
- Rising retail pressures for chemists/pharmacies
- MARKET INDICATORS
- Table 1 Consumer Expenditure on Health Goods and Medical Services
2003-2008
- Table 2 Life Expectancy at Birth 2003-2008
- MARKET DATA
- Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
- Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
- Table 5 OTC Healthcare Company Shares by Value 2004-2008
- Table 6 OTC Healthcare Brand Shares by Value 2005-2008
- Table 7 Penetration of Private Label by Sector 2003-2008
- Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis
2003-2008
- Table 9 Sales of OTC Healthcare by Sector and Distribution Format: %
Analysis 2008
- Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
- Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth
2008-2013
- APPENDIX
- OTC Registration and Classification
- Vitamins and Dietary Supplements Registration and Classification
- Self-medication and Preventative Medicine
- Generics
- Switches
- Summary 1 OTC Healthcare Switches 2005-2008
- DEFINITIONS
- Summary 2 Research Sources
- LOCAL COMPANY PROFILES - AUSTRALIA
- EGO PHARMACEUTICALS PTY LTD - OTC HEALTHCARE - AUSTRALIA
- STRATEGIC DIRECTION
- KEY FACTS
- Summary 3 Ego Pharmaceuticals Pty Ltd: Key Facts
- COMPANY BACKGROUND
- PRODUCTION
- COMPETITIVE POSITIONING
- Summary 4 Ego Pharmaceuticals Pty Ltd: Competitive Position 2008
- HERRON PHARMACEUTICALS PTY LTD - OTC HEALTHCARE - AUSTRALIA
- STRATEGIC DIRECTION
- KEY FACTS
- Summary 5 Herron Pharmaceuticals Pty Ltd: Key Facts
- COMPANY BACKGROUND
- PRODUCTION
- COMPETITIVE POSITIONING
- Summary 6 Herron Pharmaceuticals Pty Ltd: Competitive Position 2008
- INOVA PHARMACEUTICALS (AUSTRALIA) PTY LTD - OTC HEALTHCARE - AUSTRALIA
- STRATEGIC DIRECTION
- KEY FACTS
- Summary 7 iNova Pharmaceuticals (Australia) Pty Ltd: Key Facts
- COMPANY BACKGROUND
- PRODUCTION
- Summary 8 iNova Pharmaceuticals (Australia) Pty Ltd: Production
Statistics 2008
- COMPETITIVE POSITIONING
- Summary 9 iNova Pharmaceuticals (Australia) Pty Ltd: Competitive
Position 2008
- PHARMACARE LABORATORIES PTY LTD - OTC HEALTHCARE - AUSTRALIA
- STRATEGIC DIRECTION
- KEY FACTS
- Summary 10 Pharmacare Laboratories Pty Ltd: Key Facts
- COMPANY BACKGROUND
- PRODUCTION
- COMPETITIVE POSITIONING
- Summary 11 Pharmacare Laboratories Pty Ltd: Competitive Position 2008
- SYMBION HEALTH LTD - OTC HEALTHCARE - AUSTRALIA
- STRATEGIC DIRECTION
- KEY FACTS
- Summary 12 Symbion Health Ltd: Key Facts
- Summary 13 Symbion Health Ltd: Operational Indicators
- COMPANY BACKGROUND
- PRODUCTION
- Summary 14 Symbion Health Ltd: Production Statistics 2008
- COMPETITIVE POSITIONING
- Summary 15 Symbion Health Ltd: Competitive Position 2008
- ANALGESICS IN AUSTRALIA
- HEADLINES
- TRENDS
- SWITCHES
- COMPETITIVE LANDSCAPE
- PROSPECTS
- SECTOR DATA
- Table 12 Sales of Analgesics by Subsector: Value 2003-2008
- Table 13 Sales of Analgesics by Subsector: % Value Growth 2003-2008
- Table 14 Herbal vs Standard Topical Analgesics 2003-2008
- Table 15 Topical Analgesics by Format: % Value Breakdown 2004-2008
- Table 16 Analgesics Company Shares by Value 2004-2008
- Table 17 Analgesics Brand Shares by Value 2005-2008
- Table 18 Forecast Sales of Analgesics by Subsector: Value 2008-2013
- Table 19 Forecast Sales of Analgesics by Subsector: % Value Growth
2008-2013
- COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN AUSTRALIA
- HEADLINES
- TRENDS
- SWITCHES
- COMPETITIVE LANDSCAPE
- PROSPECTS
- SECTOR DATA
- Table 20 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by
Subsector: Value 2003-2008
- Table 21 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by
Subsector: % Value Growth 2003-2008
- Table 22 Sales of Decongestants by Type: Value 2003-2008
- Table 23 Sales of Decongestants by Type: % Value Growth 2003-2008
- Table 24 Sales of Child-specific Cough, Cold and Allergy (Hay Fever)
Remedies by Type: Value 2003-2008
- Table 25 Sales of Child-specific Cough, Cold and Allergy (Hay Fever)
Remedies by Type: % Value Growth 2003-2008
- Table 26 Sales of Child-specific Cough, Cold and Allergy (Hay Fever)
Remedies by Type: Value 2003-2008
- Table 27 Sales of Child-specific Cough, Cold and Allergy (Hay Fever)
Remedies by Type: % Value Growth 2003-2008
- Table 28 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies
2003-2008
- Table 29 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by
Value 2004-2008
- Table 30 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by
Value 2005-2008
- Table 31 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies
by Subsector: Value 2008-2013
- Table 32 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies
by Subsector: % Value Growth 2008-2013
- DIGESTIVE REMEDIES IN AUSTRALIA
- HEADLINES
- TRENDS
- SWITCHES
- COMPETITIVE LANDSCAPE
- PROSPECTS
- SECTOR DATA
- Table 33 Sales of Digestive Remedies by Subsector: Value 2003-2008
- Table 34 Sales of Digestive Remedies by Subsector: % Value Growth
2003-2008
- Table 35 Herbal vs Standard Digestive Remedies 2003-2008
- Table 36 Digestive Remedies Company Shares by Value 2004-2008
- Table 37 Digestive Remedies Brand Shares by Value 2005-2008
- Table 38 Forecast Sales of Digestive Remedies by Subsector: Value
2008-2013
- Table 39 Forecast Sales of Digestive Remedies by Subsector: % Value
Growth 2008-2013
- MEDICATED SKIN CARE IN AUSTRALIA
- HEADLINES
- TRENDS
- SWITCHES
- COMPETITIVE LANDSCAPE
- PROSPECTS
- SECTOR DATA
- Table 40 Sales of Medicated Skin Care by Subsector: Value 2003-2008
- Table 41 Sales of Medicated Skin Care by Subsector: % Value Growth
2003-2008
- Table 42 Acne Treatments by Format: % Value Breakdown 2004-2008
- Table 43 Medicated Skin Care Company Shares by Value 2004-2008
- Table 44 Medicated Skin Care Brand Shares by Value 2005-2008
- Table 45 Acne Treatments Brand Shares by Value 2005-2008
- Table 46 Hair Loss Treatments Brand Shares by Value 2005-2008
- Table 47 Forecast Sales of Medicated Skin Care by Subsector: Value
2008-2013
- Table 48 Forecast Sales of Medicated Skin Care by Subsector: % Value
Growth 2008-2013
- VITAMINS AND DIETARY SUPPLEMENTS IN AUSTRALIA
- HEADLINES
- TRENDS -- VITAMINS
- TRENDS -- DIETARY SUPPLEMENTS
- COMPETITIVE LANDSCAPE
- PROSPECTS
- SECTOR DATA
- Table 49 Dietary Supplements: Brand Ranking by Positioning 2008
- Table 50 Sales of Vitamins and Dietary Supplements by Subsector: Value
2003-2008
- Table 51 Sales of Vitamins and Dietary Supplements by Subsector: % Value
Growth 2003-2008
- Table 52 Folic Acid v Other B Vitamins 2004-2008
- Table 53 Dietary Supplements by Positioning 2006-2008
- Table 54 Vitamins and Dietary Supplements Company Shares by Value
2004-2008
- Table 55 Vitamins and Dietary Supplements Brand Shares by Value 2005-2008
- Table 56 Vitamins Brand Shares by Value 2005-2008
- Table 57 Dietary Supplements Brand Shares by Value 2005-2008
- Table 58 Forecast Sales of Vitamins and Dietary Supplements by
Subsector: Value 2008-2013
- Table 59 Forecast Sales of Vitamins and Dietary Supplements by
Subsector: % Value Growth 2008-2013
- NRT SMOKING CESSATION AIDS IN AUSTRALIA
- HEADLINES
- TRENDS
- SWITCHES
- COMPETITIVE LANDSCAPE
- PROSPECTS
- SECTOR INDICATORS
- Table 60 Number of Smokers by Gender 2003-2008
- SECTOR DATA
- Table 61 Sales of Smoking Cessation Aids by Subsector: Value 2003-2008
- Table 62 Sales of Smoking Cessation Aids by Subsector: % Value Growth
2003-2008
- Table 63 NRT Gum Flavours: % Value Breakdown 2006-2008
- Table 64 Smoking Cessation Aids Company Shares by Value 2004-2008
- Table 65 Smoking Cessation Aids Brand Shares by Value 2005-2008
- Table 66 Forecast Sales of Smoking Cessation Aids by Subsector: Value
2008-2013
- Table 67 Forecast Sales of Smoking Cessation Aids by Subsector: % Value
Growth 2008-2013
- EYE CARE IN AUSTRALIA
- HEADLINES
- SECTOR DATA
- Table 68 Sales of Eye Care by Subsector: Value 2003-2008
- Table 69 Sales of Eye Care by Subsector: % Value Growth 2003-2008
- Table 70 Standard Eye Care by Type: % Value Breakdown 2007-2008
- Table 71 Eye Care Company Shares by Value 2004-2008
- Table 72 Eye Care Brand Shares by Value 2005-2008
- Table 73 Forecast Sales of Eye Care by Subsector: Value 2008-2013
- Table 74 Forecast Sales of Eye Care by Subsector: % Value Growth
2008-2013
- EAR CARE IN AUSTRALIA
- HEADLINES
- SECTOR DATA
- Table 75 Sales of Ear Care: Value 2003-2008
- Table 76 Sales of Ear Care: % Value Growth 2003-2008
- Table 77 Ear Care Company Shares by Value 2004-2008
- Table 78 Ear Care Brand Shares by Value 2005-2008
- Table 79 Forecast Sales of Ear Care: Value 2008-2013
- Table 80 Forecast Sales of Ear Care: % Value Growth 2008-2013
- ADULT MOUTH CARE IN AUSTRALIA
- HEADLINES
- SECTOR DATA
- Table 81 Sales of Adult Mouth Care: Value 2003-2008
- Table 82 Sales of Adult Mouth Care: % Value Growth 2003-2008
- Table 83 Adult Mouth Care Company Shares by Value 2004-2008
- Table 84 Adult Mouth Care Brand Shares by Value 2005-2008
- Table 85 Forecast Sales of Adult Mouth Care: Value 2008-2013
- Table 86 Forecast Sales of Adult Mouth Care: % Value Growth 2008-2013
- CALMING AND SLEEPING PRODUCTS IN AUSTRALIA
- HEADLINES
- SECTOR DATA
- Table 87 Sales of Calming and Sleeping Products: Value 2003-2008
- Table 88 Sales of Calming and Sleeping Products: % Value Growth 2003-2008
- Table 89 Calming and Sleeping Products Company Shares by Value 2004-2008
- Table 90 Calming and Sleeping Products Brand Shares by Value 2005-2008
- Table 91 Forecast Sales of Calming and Sleeping Products: Value 2008-2013
- Table 92 Forecast Sales of Calming and Sleeping Products: % Value Growth
2008-2013
- WOUND TREATMENTS IN AUSTRALIA
- HEADLINES
- SECTOR DATA
- Table 93 Sales of Wound Treatments by Subsector: Value 2003-2008
- Table 94 Sales of Wound Treatments by Subsector: % ValueGrowth 2003-2008
- Table 95 Wound Treatments Company Shares by Value 2004-2008
- Table 96 Wound Treatments Brand Shares by Value 2005-2008
- Table 97 Forecast Sales of Wound Treatments by Subsector: Value 2008-2013
- Table 98 Forecast Sales of Wound Treatments by Subsector: % Value Growth
2008-2013
- OTC OBESITY IN AUSTRALIA
- HEADLINES
- SECTOR DATA
- Table 99 Sales of OTC Obesity: Value 2004-2008
- Table 100 Sales of OTC Obesity: % Value Growth 2004-2008
- Table 101 OTC Obesity Company Shares by Value 2004-2008
- Table 102 OTC Obesity Brand Shares by Value 2005-2008
- Table 103 Forecast Sales of OTC Obesity: Value 2008-2013
- Table 104 Forecast Sales of OTC Obesity: % Value Growth 2008-2013
- EMERGENCY CONTRACEPTION IN AUSTRALIA
- HEADLINES
- SECTOR DATA
- Table 105 Sales of Emergency Contraception: Value 2004-2008
- Table 106 Sales of Emergency Contraception: % Value Growth 2004-2008
- Table 107 Emergency Contraception Company Shares by Value 2004-2008
- Table 108 Emergency Contraception Brand Shares by Value 2005-2008
- Table 109 Forecast Sales of Emergency Contraception: Value 2008-2013
- Table 110 Forecast Sales of Emergency Contraception: % Value Growth
2008-2013
